Teen cannabis study seeks clues to relapse in brain chemistry
NCT ID NCT05396638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how cannabis use changes natural brain chemicals in adolescents aged 14 to 25. Researchers will measure cannabinoid and endorphin levels in blood to find markers that could tell which teens might relapse and which stay sober. The goal is to better understand cannabis's effects on the brain, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could cannabis help fight diabetes? a study investigates
- A 5-session toolkit aims to curb teen cannabis use — will it work?
- Talking through pain: could emotional awareness therapy help those on medical cannabis?
- Can a simple guide help clinicians better address youth substance use?
- Can a common nerve pain drug restore brain chemistry in bipolar cannabis users?
- Genes may determine who gets hooked or psychotic from cannabis